Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions
European Comission
ExpectedOutcome :
Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes
- Childhood cancer patients, survivors and their families benefit from enhanced quality of life through better supportive care, personalised counselling approaches, and digital tools that are accessible and affordable. Consequently, they can better achieve their values and personal life goals.
- Health care professionals, supportive workers and councillors enhance the quality of life for childhood cancer patients, survivors and their families. Scope :
Best practices and tools to improve the quality of life for survivors of childhood cancer exist at national, regional and local level. These practices and tools should be scaled up or deployed in regions in at least three different Member States or Associated Countries in order to serve as demonstrators for wider uptake.
Proposals should address all of the following:
- Best practices and validated tools (such as digital tools) related to for example education, sports, employment, medical follow-up including mental and physical health and well-being, or reproductive matters, should be tested and scaled up in regions in at least three different Member States or Associated Countries;
- Address hurdles, factors and situations that impede implementation of good practices and tools in real-life settings with the intention to make the life of childhood cancer survivors easier and better. Effectiveness and general applicability should be assessed and evaluated to provide enhanced real solutions in practice;
- Attention should be paid to social and health determinants, including sex, gender, age and other relevant variables, such as socio-economic status, living in rural or remote areas and education;
- Several best practices and tools should be chosen and scaled up together with childhood cancer survivors and their families. The use of participative research models, such as oncology-centred living labs[1] or other approaches to deliver (social) innovation should be considered.
This topic requires the effective contribution of SSH disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.
The successful proposal is expected to liaise with and build on resources made available by the Knowledge Centre on Cancer (KCC)[2] in order to foster EU alignment and coordination.
Successful applicants should closely monitor and take into account the outcomes of the project supported under topic HORIZON-MISS-2021-CANCER-02-02, (Develop and validate a set of quality of life and patient preference measures for cancer patients and survivors[3]).
The Commission will facilitate Mission-specific coordination through future actions. Hence, successful applicants will be asked to join the ‘Quality of life’ cluster for the Mission on Cancer together with the aforementioned project[4]. In this regard, the Commission will take on the role of facilitator, including with relevant initiatives and stakeholders, if appropriate.
Therefore, proposals should include a budget for networking, attendance at meetings, and potential joint activities without the prerequisite to give details of these at this stage. Examples of these activities are the organisation of joint workshops, the exchange of knowledge, the establishment best practices, or the initiation of joint communication activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate.
The details of joint activities will be defined during the grant agreement preparation phase and during the life of the project.
[2]Hosted by the European Commission's Joint Research Centre (JRC). Especially through the ’European Guidelines and Quality Assurance Schemes for Breast, Colorectal and Cervical Cancer Screening and Diagnosis‘, and the ’European Cancer Information System (ECIS)’ and the ’European Cancer Inequalities Registry (ECIR), see https://knowledge4policy.ec.europa.eu/cancer_en
[3]https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-miss-2021-cancer-02-02
[4]In order to address the objectives of the Mission on Cancer, participants will collaborate in project clusters to leverage EU-funding, increase networking across sectors and disciplines, and establish a portfolio of Cancer Mission R&I and policy actions.
General conditions
- Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
- Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide .
- Other eligibility conditions: described in Annex B of the Work Programme General Annexes
A written commitment is required from the participating regions in which the action proposed will be implemented, expressed by a letter of intent annexed to the proposal and signed by the corresponding authority/ies.
Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes
Evaluation and award:
- Award criteria, scoring and thresholds are described in Annex D of the Work Programme General Annexes
The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 3 (Implementation). The cumulative threshold will be 12.
Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual
Indicative timeline for evaluation and grant agreement: described in Annex F of the Work Programme General Annexes
- Legal and financial set-up of the grants: described in Annex G of the Work Programme General Annexes
Specific conditions
- Specific conditions: described in the [specific topic of the Work Programme]
Documents
Call documents:
Standard application form — call-specific application form is available in the Submission System
Standard application form (HE RIA, IA) [
](https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-erc-cog_en.pdf) Standard evaluation form — will be used with the necessary adaptations
Standard evaluation form (HE RIA, IA)
MGA
Call-specific instructions
Information on clinical studies (HE)
Additional documents:
HE Main Work Programme 2023–2024 – 1. General Introduction
HE Main Work Programme 2023–2024 – 12. Missions
HE Main Work Programme 2023–2024 – 13. General Annexes
HE Framework Programme and Rules for Participation Regulation 2021/695
HE Specific Programme Decision 2021/764
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement
Funding & Tenders Portal Online Manual